UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000003759
Receipt number R000004554
Scientific Title Endothelial Function Study
Date of disclosure of the study information 2010/06/15
Last modified on 2021/06/24 18:37:51

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Endothelial Function Study

Acronym

Endothelial Function Study

Scientific Title

Endothelial Function Study

Scientific Title:Acronym

Endothelial Function Study

Region

Japan


Condition

Condition

Cardiovascular disease, Hypertension, Diabetes mellitus, Dyslipidemia, Subjects with coronary risk factors, healthy subjects

Classification by specialty

Medicine in general Cardiology Vascular surgery
Obstetrics and Gynecology

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

The purpose of this study was to evaluate 1) endothelial function in ardiovascular disease, Hypertension, Diabetes mellitus, Dyslipidemia, Subjects with coronary risk factors, and healthy subjects, 2) the effects of pharmacological interventions on endothelial function

Basic objectives2

Others

Basic objectives -Others

The purpose of this study was to evaluate role of endothelial function in cardiovascular outcomes.

Trial characteristics_1


Trial characteristics_2


Developmental phase

Not applicable


Assessment

Primary outcomes

endothelial function

Key secondary outcomes



Base

Study type

Interventional


Study design

Basic design

Single arm

Randomization

Non-randomized

Randomization unit


Blinding

Single blind -investigator(s) and assessor(s) are blinded

Control

Uncontrolled

Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms

1

Purpose of intervention

Prevention

Type of intervention

Other

Interventions/Control_1

Endothelial function

Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

18 years-old <=

Age-upper limit

100 years-old >

Gender

Male and Female

Key inclusion criteria

Patients with cardiovascular diseases, hypertension, diabetes mellitus, dyslipidemia and subjects with coronary risk factors are enrolled in this study.

Key exclusion criteria

Subjects who were not able to be obtained written informed consent for participation were excluded in this study.

Target sample size

10000


Research contact person

Name of lead principal investigator

1st name
Middle name
Last name Yukihito Higashi

Organization

Hiroshima University Hospital

Division name

Division of Regenerative Medicine

Zip code


Address

1-2-3 Kasumi, Minamiku, Hiroshima

TEL

082-257-5122

Email



Public contact

Name of contact person

1st name
Middle name
Last name Yukihito Higashi

Organization

Hiroshima university Hospital

Division name

Division of Regenerative Medicine

Zip code


Address

1-2-3 kasumi, minamiku, hiroshima

TEL

082-257-5122

Homepage URL

http://home.hiroshima-u.ac.jp/angio/

Email

yhigashi@hiroshima-u.ac.jp


Sponsor or person

Institute

Hiroshima University

Institute

Department

Personal name



Funding Source

Organization

This study was supported in part by a Grant-in-Aid for Scientific Research from the Ministry of Education, Science and Culture of Japan (1859081500 and 21590898).

Organization

Division

Category of Funding Organization

Nationality of Funding Organization

Japan


Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization


Address


Tel


Email



Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2010 Year 06 Month 15 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Completed

Date of protocol fixation

1998 Year 04 Month 01 Day

Date of IRB

1998 Year 04 Month 01 Day

Anticipated trial start date

1998 Year 07 Month 01 Day

Last follow-up date

2017 Year 04 Month 01 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information



Management information

Registered date

2010 Year 06 Month 15 Day

Last modified on

2021 Year 06 Month 24 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000004554


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name